SPY328.73+5.23 1.62%
DIA271.70+3.60 1.34%
IXIC10,913.56+241.30 2.26%

Morgan Stanley Downgrades Unity Biotechnology to Equal-Weight, Announces $5 Price Target

Morgan Stanley analyst Matthew Harrison downgrades Unity Biotechnology (NASDAQ:UBX) from Overweight to Equal-Weight and announces $5 price target.

Benzinga · 08/18/2020 11:21
Morgan Stanley analyst Matthew Harrison downgrades Unity Biotechnology (NASDAQ: UBX) from Overweight to Equal-Weight and announces $5 price target.